Metformin, an oral medication used to treat type 2 diabetes, is often prescribed off-label for weight loss. It helps to control blood sugar by reducing both the amount of glucose produced by the liver ...

Losing weight is one of the most common metformin side effects. Learn more about what the drug is, how it works, and if it’s a diabetes treatment for you.

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...

Metformin is a generic prescription drug that works to treat type 2 diabetes by helping lower your blood sugar levels. Your response to this drug may vary based on your medical history and diagnosis.

Whenever you start taking a new medication to treat a certain symptom or condition, it’s natural to wonder if the medicine is really making a difference for your health. When it comes to people who ...

When Is the Best Time to Take Metformin? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. We get it — no one enjoys taking medications. It’s just another thing to tackle on your ...

Whenever you start taking a new medication to treat a certain symptom or condition, it’s natural to wonder if the medicine is really making a difference for your health. When it comes to people who ...

The increasing popularity of weight loss drugs like Wegovy®, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other? How do ...

The commonly used diabetes drug metformin may reduce risk for cancer, according to study results published in Journal of the National Cancer Institute. A systematic review and meta-analysis of 166 ...

People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according ...

Metformin use is linked to improved survival rates in patients with ovarian cancer, particularly among those with diabetes and serous cancers, though further research is needed to confirm these ...